Literature DB >> 9638141

Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors.

L Mselli-Lakhal1, C Favier, M F Da Silva Teixeira, K Chettab, C Legras, C Ronfort, G Verdier, J F Mornex, Y Chebloune.   

Abstract

Replication defective retroviral vectors are regularly used for transfer and expression of exogenous genes into dividing cells and in animals. Since lentiviruses are able to infect terminally differentiated and non-dividing cells, their use to produce replication defective vectors may overcome this limitation. We developed two replication-defective lentiviral vectors based on the genome of Caprine Arthritis Encephalitis Virus (CAEV). The first vector (pBNL2) carries the neo and lacZ marker genes. Neo gene is expressed from a genomic RNA and lacZ gene from a subgenomic RNA. The second vector (pCSHL) carries a single fusion gene encoding both phleomycin resistance and beta-galactosidase activity. Replication-competent CAEV was used as helper virus to provide the viral proteins for transcomplementation of these vectors. Our data demonstrated that the genomes of both vectors were packaged into CAEV virions and transduced into goat synovial membrane cells following infection. However, the vector titers remained 3 to 4 logs lower than those of CAEV. Further analysis showed a lack of accumulation of unspliced pBNL2 RNA into the cytoplasm of producer cells resulting in the packaging of pBNL2 sub-genomic RNA only. In contrast, RNA produced from pCSHL vector was correctly transported to the cytoplasm and more efficiently packaged than the pBNL2 sub-genomic RNA as revealed by slot-blot and quantitative RT/PCR analyses. However this higher packaging efficiency of pCSHL genome did not result in a higher transduction efficiency of lacZ gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9638141     DOI: 10.1007/s007050050323

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  Host range of small-ruminant lentivirus cytopathic variants determined with a selectable caprine arthritis- encephalitis virus pseudotype system.

Authors:  I Hötzel; W P Cheevers
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells.

Authors:  L Mselli-Lakhal; C Favier; K Leung; F Guiguen; D Grezel; P Miossec; J F Mornex; O Narayan; G Querat; Y Chebloune
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.

Authors:  J P O'Rourke; G C Newbound; D B Kohn; J C Olsen; B A Bunnell
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 4.  The inside out of lentiviral vectors.

Authors:  Stéphanie Durand; Andrea Cimarelli
Journal:  Viruses       Date:  2011-02-14       Impact factor: 5.818

5.  The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events.

Authors:  Bing Zhang; Pat Metharom; Howard Jullie; Kay AO Ellem; Geoff Cleghorn; Malcolm J West; Ming Q Wei
Journal:  Genet Vaccines Ther       Date:  2004-08-04

Review 6.  Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders.

Authors:  Vincenzo Cavalieri; Elena Baiamonte; Melania Lo Iacono
Journal:  Viruses       Date:  2018-06-09       Impact factor: 5.048

Review 7.  Gene Therapy Applications of Non-Human Lentiviral Vectors.

Authors:  Altar M Munis
Journal:  Viruses       Date:  2020-09-29       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.